INTUITIVE SURGICAL INC
▲ 1 upgrades / ▼ 0 downgrades / 11 reiterations from 10 firms
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 21, 2026 | Leerink Partners | maintain | Outperform → Outperform | $503 | 51% |
| Oct 21, 2026 | JP Morgan | maintain | Overweight → Overweight | $475 | 54% |
| Oct 21, 2026 | Evercore ISI Group | maintain | In-Line → In-Line | $385 | 58% |
| Oct 21, 2026 | Wells Fargo | maintain | Overweight → Overweight | $486 | 54% |
| Oct 21, 2026 | TD Cowen | reiterate | Buy → Buy | $485 | 54% |
| Oct 21, 2026 | Barclays | maintain | Overweight → Overweight | $500 | 53% |
| Oct 21, 2026 | RBC Capital | maintain | Outperform → Outperform | $550 | 55% |
| Oct 21, 2026 | Mizuho | maintain | Neutral → Neutral | $400 | 52% |
| Oct 21, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| Oct 21, 2026 | BTIG | reiterate | Buy → Buy | $454 | 52% |
| Oct 12, 2026 | BTIG | maintain | Buy → Buy | $454 | 52% |
| Oct 7, 2026 | Barclays | initiate | — → Overweight | $485 | 53% |
| Sep 8, 2026 | BTIG | reiterate | Buy → Buy | $469 | 52% |
| Aug 12, 2026 | Oppenheimer | upgrade | Perform → Outperform | $500 | 52% |
| Jul 30, 2026 | HSBC | downgrade | Buy → Hold | $931 | 53% |
| Jul 17, 2026 | Raymond James | maintain | Outperform → Outperform | $483 | 54% |
| Jul 17, 2026 | Piper Sandler | reiterate | Overweight → Overweight | $470 | 54% |
| Jul 17, 2026 | JP Morgan | maintain | Overweight → Overweight | $450 | 54% |
| Jul 17, 2026 | Mizuho | maintain | Neutral → Neutral | $400 | 52% |
| Jul 17, 2026 | Wells Fargo | maintain | Overweight → Overweight | $487 | 54% |
| Jul 17, 2026 | TD Cowen | maintain | Buy → Buy | $485 | 54% |
| Jul 17, 2026 | Evercore ISI Group | maintain | In-Line → In-Line | $375 | 58% |
| Jul 17, 2026 | RBC Capital | maintain | Outperform → Outperform | $575 | 55% |
| Jul 17, 2026 | Stifel | maintain | Buy → Buy | $550 | 53% |
| Jul 17, 2026 | Citigroup | maintain | Buy → Buy | $500 | 54% |
| Jul 17, 2026 | Bernstein | maintain | Outperform → Outperform | $685 | 52% |
| Jul 17, 2026 | Leerink Partners | maintain | Outperform → Outperform | $454 | 51% |
| Jul 17, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| Jul 17, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Jul 16, 2026 | Truist Securities | maintain | Buy → Buy | $510 | 54% |
| Jul 15, 2026 | Mizuho | maintain | Neutral → Neutral | $500 | 52% |
| Jul 13, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Jul 13, 2026 | RBC Capital | maintain | Outperform → Outperform | $600 | 55% |
| Jul 9, 2026 | BMO Capital | initiate | — → Outperform | $518 | 53% |
| Jul 6, 2026 | Evercore ISI Group | maintain | In-Line → In-Line | $430 | 58% |
| May 18, 2026 | B of A Securities | maintain | Buy → Buy | $520 | 53% |
| Apr 23, 2026 | Barclays | maintain | Overweight → Overweight | $651 | 53% |
| Apr 22, 2026 | Leerink Partners | maintain | Outperform → Outperform | $573 | 51% |
| Apr 22, 2026 | Baird | maintain | Outperform → Outperform | $610 | 55% |
| Apr 22, 2026 | Piper Sandler | maintain | Overweight → Overweight | $580 | 54% |
| Apr 22, 2026 | BTIG | reiterate | Buy → Buy | $574 | 52% |
| Apr 15, 2026 | Truist Securities | maintain | Buy → Buy | $580 | 54% |
| Apr 13, 2026 | Mizuho | maintain | Neutral → Neutral | $525 | 52% |
| Apr 10, 2026 | BTIG | reiterate | Buy → Buy | $616 | 52% |
| Apr 9, 2026 | Goldman Sachs | maintain | Buy → Buy | $609 | 54% |
| Apr 6, 2026 | Evercore ISI Group | maintain | In-Line → In-Line | $480 | 58% |
| Mar 17, 2026 | UBS | maintain | Neutral → Neutral | $550 | 54% |
| Mar 11, 2026 | Citigroup | upgrade | Neutral → Buy | $590 | 54% |
| Feb 24, 2026 | UBS | maintain | Neutral → Neutral | $570 | 54% |
| Jan 27, 2026 | Freedom Capital Markets | upgrade | Hold → Buy | $610 | 43% |
No cross-platform signals in the last 90 days